Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.: FDA Warning Letter, Aug 6, 2026

Status: Unknown as of Oct 16, 2026. Warning letters are informal and advisory, not final agency action. Original on FDA.gov.

Company
Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. (as published by FDA)
Letter date
Aug 6, 2026
Posted
Aug 18, 2026
Office
Center for Drug Evaluation and Research (CDER)
Subject
“CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded”
Response
None posted by FDA as of last check
Close-out
None posted by FDA as of last check
Source
FDA.gov · retrieved Oct 16, 2026

Get new FDA warning letters by email. One digest a week, free.

Double opt-in: we email you a link to confirm. One-click unsubscribe in every email. You must be at least 18. See our Privacy policy.

Need it same day for your suppliers? Reserve a founding Pro seat.

Topics: Drug manufacturing (CGMP)

Text above is quoted or paraphrased from FDA.

Something wrong or out of date? Request a correction. We review correction requests within 5 business days.

← All letters